1 (Labetalol Hydrochloride Injection Pfs 1)
Labetalol Hydrochloride Injection, Solution
Product Images NDC 70121-2428
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 70121-2428). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
2 (Labetalol Hydrochloride Injection Pfs 2)
3 (Labetalol Hydrochloride Injection Pfs 3)
03 (Labetalol Hydrochloride Injection Pfs 4)
04 (Labetalol Hydrochloride Injection Pfs 5)
10 (Labetalol Hydrochloride Injection Pfs 6)
This text provides information about a Labetalol Hydrochloride Injection in a 4mL single-dose syringe, with a concentration of 20 mg/4 mL (6 mg/ml). It specifies that the injection is for intravenous use only and should be retained in the carton until the time of use. It warns to protect the product from freezing and light and to discard any unused portion. The product is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ, with manufacturing in India. The provided manufacturing license number is G/28/1539 Rev. 08-2025-00. The label includes an expiration date and specifies to use it only under prescription.*
11 (Labetalol Hydrochloride Injection Pfs 7)
The text describes information regarding Labetalol Hydrochloride Injection, USP, distributed by Amneal Pharmaceuticals LLC. The product is intended for intravenous injection only and should be stored between 20°C to 25°C. It contains 100 mg of labetalol hydrochloride, 0.08 mg of methylparaben, and 0.1 mg of propylparaben as preservatives. The packaging includes a 4mL single-dose syringe without a needle. Instructions recommend protecting the product from freezing and light, retaining it in the carton until use, and discarding any unused portion. The labetalol hydrochloride injection is indicated for use in adults as per standard dosage and administration route.*
12 (Labetalol Hydrochloride Injection Pfs 8)
This text is a detailed description of Labetalol Hydrochloride Injection, USP, a medication available in single-dose syringes with 20 mg/4 mL concentration for intravenous use. The product is manufactured in India and distributed by Amneal Pharmaceuticals LLC. It contains labetalol hydrochloride, anhydrous dextrose, edetate disodium, citric acid monohydrate, sodium hydroxide, methylparaben, and propylparaben as preservatives. Instructions for storage and administration, along with the manufacturer's details and lot information, are provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
